Medimmune

MedImmune, the global biologics unit of AstraZeneca, is committed to developing better medicines that help people live healthier, longer and more satisfying lives. The company is focused on the areas of infection, respiratory and inflammatory disease, oncology and neuroscience, with two marketed products and a robust pipeline of promising new product candidates. MedImmune’s state-of-the-art Cambridge site (formerly Cambridge Antibody Technology) serves the company’s European hub for research and development.

MedImmune’s R&D facilities in Cambridge, UK with its distinctive science and culture, is central to AstraZeneca’s plans to establish a major international presence in the research and development of biological therapeutics.

Website: www.medimmune.com
Contact name: Ray Field